5results about How to "Slow down heart rate" patented technology

The utility model discloses a multifunctional operating bed, wherein, including: lift base, bed body, heating water pad, massage device, controller, playing device, control system, lift base is installed in the lower surface of bed body, heating water pad is installed in the upper surface of bed body, massage device is installed in the upper surface of bed body, two playing devices are installed in the lateral wall of bed body, and two controllers are located in the both sides of massage device, control system is installed in bed body, and control system is connected with heating water pad, massage device, playing device and controller electricity. Through the device, the comfort of patient operation can be increased, and the nervousness is reduced.

The present invention discloses a Chinese medicine composition for treating chronic heart failure, wherein the Chinese medicine composition comprises the following raw materials: 45-55 parts of raw astragalus, 10-18 parts of epimedium, 10-18 parts of scutellaria, 10-18 parts of tiliaceus, 10-18 parts of tuckahoe, 10-18 parts of stir-fried atractylodes, 10-18 parts of acanthopanax, 10-18 parts of salvia miltiorrhiza, 9-12 parts of ophiopogon, and 9-12 parts of cassia twig. The present invention also discloses a preparation method for providing the above-mentioned Chinese medicine composition, and the application of the above-mentioned Chinese medicine composition in the preparation of a drug for treating chronic heart failure. The Chinese medicine composition of the present invention can inhibit and delay the development of myocardial remodeling, block a vicious cycle, and reduce the mortality rate of patients with heart failure.

The invention discloses a cardiovascular risk grading early warning method based on pulse wave form analysis. Based on a bone conduction hearing aid device integrated with a superficial temporal artery pulse monitoring function, the following steps are executed: continuously collecting pulse signals of a superficial temporal artery of a user; the collected pulse signals are analyzed in real time, feature parameters are extracted, and the feature parameters comprise basic parameters, morphological parameters and abnormal events; according to different characteristic parameters, the risk is divided into three levels, namely, first-level early warning: light abnormity is not needed, and emergency intervention is not needed; secondary early warning: suggesting recent doctor seeing if moderate abnormality occurs; three-pole early warning: in case of serious abnormity, first aid needs to be immediately carried out; and triggering a corresponding response measure according to the risk level. According to the invention, through three-level grading and differential response, traceability of slight abnormity is ensured, and timely intervention of emergency situations is also ensured.

The present invention provides a prophylactic or therapeutic agent for hypoxia disorders, ischemia-reperfusion disorders or inflammation, a cell protective agent for transplantation, and a biological preservative. The present invention pertains to: a prophylactic or therapeutic agent for hypoxia disorders, ischemia-reperfusion disorders or inflammation; a cell protective agent for transplantation; and a biological preservative, each of which contains, as an active ingredient, at least one selected from the group consisting of: a heterocyclic compound represented by formula (I) (wherein each symbol in the formula is as defined in the description) or a salt thereof; an isothiocyanate compound represented by formula S = C = N-R5 (II) (wherein the symbols are as described in the specification); and a TRPA1 agonist. # imgabs0 #

The present invention provides a prophylactic or therapeutic agent for hypoxia disorders, ischemia-reperfusion disorders or inflammation, a cell protective agent for transplantation, and a biological preservative. The present invention pertains to: a prophylactic or therapeutic agent for hypoxia disorders, ischemia-reperfusion disorders or inflammation; a cell protective agent for transplantation; and a biological preservative, each of which contains, as an active ingredient, at least one selected from the group consisting of: a heterocyclic compound represented by formula (I) (wherein each symbol in the formula is as defined in the description) or a salt thereof; an isothiocyanate compound represented by formula S = C = N-R5 (II) (wherein the symbols are as described in the specification); and a TRPA1 agonist. # imgabs0 #